Zaniboni, Alberto <br/><br/>
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Jun 2012 
 - 1641-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-012-1875-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Camptothecin--analogs & derivatives<br/>Female<br/>Fluorouracil--therapeutic use<br/>Humans<br/>Leucovorin--therapeutic use<br/>Male<br/>Middle Aged<br/>Pancreatic Neoplasms--drug therapy<br/>Survival Rate